Continue reading here:
Virbac : Declaration of the number of shares and voting rights 03/2024
Continue reading here:
Virbac : Declaration of the number of shares and voting rights 03/2024
See the original post here:
Nicox: 2024 Ordinary and Extraordinary Shareholder Meeting
See the original post here:
QIAGEN N.V. to release results for Q1 2024 and hold webcast
View original post here:
IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models
Go here to read the rest:
Inc.’s 2024 Female Founders list highlights why female founders are always a good bet
Here is the original post:
Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results
Here is the original post:
Nuvectis Pharma to Present at the 36th Annual Roth Conference
Read more from the original source:
Eupraxia Pharmaceuticals Announces Closing of Overnight Marketed Offering for Gross Proceeds of C$33.9 Million